Non Government Organizations
Diabetes and Immune Tolerance
Research into the etiology and potential treatments for diabetes is one of the major areas of research supported by the RUCDR, involving partnerships with a number of agencies. As part of this effort, we isolate peripheral blood mononuclear cells (PBMCs) for cryopreservation, storage, and distribution to the diabetes research community.
Type 1 Diabetes TrialNet
Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes. TrialNet was established in response to the Surgeon General's Report Healthy People 2000. This report identified diabetes as a national health objective for the Nation. TrialNet is conducting clinical trials with researchers from 18 Clinical Centers in the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia and New Zealand. In addition, more than 150 medical centers and physician offices are participating in the TrialNet network. In partnership with TrialNet, RUCDR has initiated the biobank and will receive and process blood samples from all participating TrialNet collection sites. For more information, visit our partner's website.